CACNA1A and pulmonary fibrosis: The limitation of this study is that we could not exclude the possibility that the anti-inflammatory effects of MHP1-AcN in bleomycin-induced lung fibrosis model might be the cause of anti-fibrotic effects because we administered MHP1-AcN from the beginning of bleomycin.